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Background:  Early  mobility  within  the  ICU is  associated  with  a number  of positive  outcomes  including
reductions  in  ICU  and hospital  length  of  stay  and  better  functional  recovery.  The exact  deﬁnition  of
‘early’  mobility  is  still not  deﬁned,  with  the  actual  ability  to mobilise  limited  by  a  number  of  perceived
factors.  The  Sara  Combilizer  is a combined  tilt table  and  stretcher  chair,  which  allows  passive  transfer  of
patients  out  of  bed.  This  study  aimed  to assess  whether  the  introduction  of  the Sara  Combilizer  reduced
time  taken  to  ﬁrst  mobilise  for  patients  mechanically  ventilated  for at least  ﬁve  days  and  at  risk  of  ICU
acquired  weakness.
Methods: Patients  admitted  to a large  UK  critical  care  unit  during  the trial  period  and  ventilated  for  ≥5  days
were included  in the  study.  Baseline  data  was  collected  prospectively  for a  period  of  four  months.  The
Sara  Combilizer  was then  introduced  for a one  month  training  and  familiarisation  period,  followed  by
a  further  four  months  prospective  data  collection.  The  primary  outcome  was  time  to  ﬁrst  mobilisation,
deﬁned  as a Manchester  Mobility  Score  ≥2.
Results: Following  the  introduction  of  the  Sara  Combilizer,  time  taken  to mobilise  reduced  signiﬁcantly
from  13.6  to 10.6  days  (p  =  0.028).  SOFA  scores  were  signiﬁcantly  higher  at the  point  of  ﬁrst  mobilisation
in  the  Combilizer  group  (mean:  2.9  ±  0.5  vs. 5.1  ±  2.4;  p = 0.005).  There  was  no  statistical  difference  in
therapy  time  between  the  groups,  or ICU  or hospital  length  of stay.
Conclusions:  The  introduction  of  the  Sara  Combilizer  was  associated  with  a signiﬁcant  reduction  in time
to  mobilise  patients  ventilated  for ≥5 days,  and  patients  were  mobilised  with  a higher  degree  of  organ
failure.  This was  achieved  without  any increase  in  therapy  time.  The  Sara  Combilizer  may  be a  useful
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. Background
Survivors of critical illness may  experience signiﬁcant physicalPlease cite this article in press as: McWilliams D, et al. The Sara Com
prospective before and after study. Aust Crit Care (2016), http://dx.doi
nd psychological morbidity. At least half of patients discharged
re unable to return to premorbid levels of activity due primarily
o weakness and lack of endurance.1 These effects can last months
Abbreviations: HADS, Hospital Anxiety and Depression Scale; ICU, intensive care
nit; ICUAW, intensive care unit acquired weakness; LOS, length of stay; MMS,
anchester Mobility Score; MRC, Medical Research Council; SOFA, Sequential Organ
ailure Assessment; UK, United Kingdom; US, United States.
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036-7314/© 2016 Australian College of Critical Care Nurses Ltd. Published by Elsev
reativecommons.org/licenses/by-nc-nd/4.0/).otocol  within  the  ICU.
f  Critical  Care  Nurses  Ltd.  Published  by  Elsevier  Ltd.  This is an  open access
 BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
to years after hospital discharge,2–4 with a negative impact on
employment and income in ICU survivors and their care-givers, as
well as healthcare usage.5 The weakness experienced by survivors
of critical illness is thought to be multifactorial, including premor-
bid conditions, ICU acquired weakness (ICUAW) and prolonged bed
rest.6 Longer length of mechanical ventilation is a risk factor for
ICUAW, with 55% of patients ventilated for more than eight days
developing ICUAW in one study.7 The presence of ICUAW worsens
acute morbidity and one year mortality,7 and is associated with
signiﬁcant long term physical impairments.8bilizer® as an early mobilisation aid for critically ill patients: A
.org/10.1016/j.aucc.2016.09.001
The evidence base for rehabilitation within critical care is grow-
ing, demonstrating rehabilitation to be effective in improving short
term outcomes and long term recovery in critical care patients.
Early and structured rehabilitation programs have been shown to
ier Ltd. This is an open access article under the CC BY-NC-ND license (http://
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ecrease both ICU and hospital length of stay (LOS),9–11 as well as
mprove functional ability at critical care and hospital discharge.12
his is particularly the case when led by physiotherapists.13 Specif-
cally, both Morris et al.9 and McWilliams et al.11 demonstrated
educed ICU LOS in response to earlier mobilisation, deﬁned as
itting out of bed in a chair. However, the concept of ‘early’ reha-
ilitation is not a simple one and refers to a point in the patients’
llness progression rather than a measure of a speciﬁc number of
ays. Previous research has demonstrated that patients with multi
rgan failure are most susceptible to muscle loss14 and are most
ikely to suffer delays in mobilisation due to a need for ongoing
rgan support or lung protective ventilation strategies. As such, the
ey to ‘early’ mobility here would be to commence mobilisation in
n earlier phase of the organ failure recovery than previously would
ccur.
A number of studies have explored the safety of mobilisa-
ion programs within critical care, suggesting a low incidence of
dverse events. Recent evidence suggests mobilisation can be safely
mplemented for patients still mechanically ventilated via both
racheostomy and endotracheal tubes,15 and for those receiving
ontinuous hemoﬁltration.16 In practice however, a number of per-
eived limitations to early mobilisation still exist with ongoing
oncerns regarding the safety of such interventions in the acute
hase of critical illness.16 With no clear deﬁnition or established
rotocols regarding the optimal time to start mobilisation, cou-
led with a lack of resources, large variations in practice have been
emonstrated both nationally and internationally.17–21
The Sara Combilizer (Arjo Huntleigh) is a combined chair and
ilt table which can be taken completely ﬂat to allow transfer via a
liding board (e.g. patslide), in addition to allowing standing posi-
ions to be achieved (see Figs. 1 and 2). The chair position also has a
tilt in space’ recline function which allows more supportive seat-
ng positions to be achieved in comparison to standard chairs used
ithin the ICU. Although not as challenging as sitting on the edge of
he bed, passive chair transfer does still elicit both a cardiovascular
nd respiratory exercise response.22
The aim of this study was to investigate whether the Sara Com-
ilizer could facilitate safe and early mobilisation of critically ill
atients at high risk of ICUAW who would otherwise be unable to
et out of bed, thereby reducing time to ﬁrst mobilisation.Please cite this article in press as: McWilliams D, et al. The Sara Com
prospective before and after study. Aust Crit Care (2016), http://dx.doi
. Methods
The study was conducted after approval by the local ethics com-
ittee North West—Greater Manchester South (ref: 14/NW10180).
Fig. 2. Sara Combilizer sFig. 1. Sara combiliser sitting position.
As patients lacked mental capacity at the time of recruitment, writ-
ten informed consent was gained from a personal consultee or
Registered Medical Practitioner if no personal consultee was  avail-
able. If the patient later regained mental capacity, written informed
consent was gained directly for ongoing participation in the trial.
Consecutive patients were recruited from the trauma, neuro-
sciences and general ICU of Queen Elizabeth Hospital Birmingham,
UK between July 2014 and March 2015. Physiotherapy stafﬁng is
provided at a ratio of one therapist to 10 patients. To be eligible,
patients had to be ≥18 years of age and mechanically ventilated for
ﬁve days or more. This duration was chosen to ensure a cohort ofbilizer® as an early mobilisation aid for critically ill patients: A
.org/10.1016/j.aucc.2016.09.001
patients at signiﬁcant risk of ICUAW and with limitations to sitting,
transferring or standing by conventional methods.
tanding position.
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Box 1: Contraindications to mobilisation.
- Significant dose of vasoactive agents (e.g. >0.2 mcg/kg/min
noradrenaline or equivalent) for hemodynamic stability
(Maintain Mean Arterial Pressure >60 mmHg)
- Mechanically ventilated with Fi02 >0.8 and/or PEEP
>12 cmH2O
- Active infusion of neuromuscular paralysing agent
- Acute neurological event
- Unstable spine or extremity fractures with contraindications
to mobilise
- Active bleeding process
Box 2: Restrictions to edge sitting.
- Small dose of vasoactive agents (e.g. 01–0.2 mcg/kg/min
noradrenaline or equivalent) for hemodynamic stability
(Maintain Mean Arterial Pressure >60 mmHg)
- Mechanically ventilated with Fi02 >0.6 and/or PEEP
>10 cmH2O
- Poor tolerance of endotracheal tube
- Open abdomen or high risk for dehiscence—liaise with sur-
geons prior to mobilising
- Hemofiltration via a femoral line with significant flow restric-
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Box 3: Manchester mobility score.
1. In bed interventions (passive movements, active exercise,
chair position in bed)
2. Sit on edge of bed
3. Hoisted to chair (incl. standing hoist)
4. Standing practice
5. Step transfers with assistance
6. Mobilising with or without assistancetions on movement
Patients were excluded if they had contraindications to mobil-
sation (e.g. unstable pelvic fractures or spinal injuries), severe
eurological injury or neuromuscular disease such as Guillain Barre
r motor neurone disease. Due to possible unmeasurable confound-
ng variables, patients were also excluded if they had received
echanical ventilation for >48 h at another facility immediately
rior to admission or had a poor pre admission level of mobility
<10 yards reported by patient or proxy during admission assess-
ent). Due to speciﬁc restrictions linked to the Sara Combilizer,
atients were excluded if they were over 6 ft 5 in. (1.96 m)  tall or
xceeded the weight limit of 440 lbs (200 kg).
. Design
A single centre prospective before and after study was designed
o evaluate the impact of the Sara Combilizer device on early mobil-
sation within the ICU. Baseline data was collected for four months
rior to the introduction of the product, representing current “stan-
ard of care”. After this period, a one month training and orientation
eriod was implemented to allow physiotherapy and nursing staff
o become familiar with the Sara Combilizer and gain experience
sing the device. This was then followed by a further four month
ata collection period, where four Sara Combilizers were made
reely available for use by staff. Our existing mobility protocol was
dapted to incorporate the Sara Combilizer to guide its use (see
ig. 3), alongside safety criteria adapted from previously published
uidelines23 for restrictions or contraindications for mobilisation
see Boxes 1 and 2). To summarise, this protocol recommended
se of Sara Combilizer for patients with restrictions to sitting on
he edge of the bed, as a component of a seating program or for
ngoing rehabilitation of patients unable to stand. If patients were
ble to sit on the edge of the bed this was chosen as the ﬁrst line of
reatment to allow assessment of sitting balance as well as exercisePlease cite this article in press as: McWilliams D, et al. The Sara Com
prospective before and after study. Aust Crit Care (2016), http://dx.doi
apacity and response.
Demographic data, admission reason, APACHE II scores, Charl-
on co-morbidity indices and sedation days were obtained from
ospital databases and the electronic prescribing system to assess7. Mobilising >30 m
homogeneity between groups. Sedation days was  deﬁned as greater
than 1 h of sedative infusion in a 24 h period to account for any
sedation given during procedures which may have impacted on
rehabilitation. Physical function was assessed prospectively using
the Manchester Mobility Score (MMS)24 as a measure of daily reha-
bilitation status within ICU and at ICU discharge (see Box 3). Daily
Sequential Organ Failure Assessment (SOFA) scores were calcu-
lated to allow comparisons of the degree of organ failure at the
time of ﬁrst mobilisation. The Barthel, Medical Research Council
(MRC) sum score and Hospital Anxiety and Depression Scale (HADS)
questionnaires were completed where possible at ICU and hospi-
tal discharge. Information regarding advanced respiratory support
days deﬁned as the delivery of positive pressure (including continu-
ous positive airway pressure) via an endotracheal or tracheostomy
tube, ICU LOS, mortality and functional status were collected from
the ICU charts and local physiotherapy documentation. Pressure
ulcer and falls incidence during critical care and hospital stay were
collected from the hospitals electronic database.
The primary outcome was the time to ﬁrst mobilisation, as
deﬁned as sitting on the edge of the bed or higher (MMS  score of
≥2). Secondary outcomes were SOFA score at time of ﬁrst mobili-
sation in order to assess organ failure at the point of mobilisation,
MMS  at critical care discharge, ICU length of stay (deﬁned as time
from point of admission to time declared medically ﬁt for discharge
by senior ICU clinician), duration of ventilation, ICU and hospital
mortality, Barthel score at critical care and hospital discharge, MRC
sum score and HADS score at ICU and hospital discharge, critical
care readmission rate, pressure ulcer incidence and falls incidence.
4. Statistical methods
A power calculation was  performed from pilot data using an
online power calculation tool recommended by the Trusts’ statisti-
cian (http://www.stat.ubc.ca/∼rollin/stats/ssize/n2.html). This was
based on a 2 tailed t-test, with signiﬁcance level of 0.05 and an 80%
power. Baseline mean time to mobilise for patients mechanically
ventilated for greater than 5 days was  10.6 days, with a sample stan-
dard deviation of 4.1. Based on these ﬁgures, the minimal detectable
difference was  3 days, for a sample size of 30 patients in each
phase (before & after introduction of Sara Combilizer). Therefore,
we planned recruitment of 40 patients in each phase of the study,
to allow for ICU mortality and withdrawals from the trial.
All analyses were performed using IBM SPSS Statistics 22 (IBM
Corp. Armonk, NY), with p < 0.05 deemed to be indicative of statis-
tical signiﬁcance throughout. Prior to the analysis, the distributions
of the continuous variables were assessed for normality using his-
tograms. Normally distributed variables were reported as means
and standard deviations, with comparisons between treatment
groups performed using independent samples t-tests. Skewed vari-bilizer® as an early mobilisation aid for critically ill patients: A
.org/10.1016/j.aucc.2016.09.001
ables were log10-transformed, after adding one to remove zeros, in
order to normalise their distributions. The resulting variables were
then compared between groups using independent samples t-tests,
and summarised with geometric means and 95% conﬁdence inter-
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Fig. 3. Sara Combiliser early
als. Where normality could not be achieved by transformation,
 non-parametric approach was employed, with data reported as
edians and interquartile ranges (IQR), and comparisons between
roups made using Mann–Whitney tests. For categorical variables,
isher’s exact tests were used.
. Results
A total of 80 patients were recruited, of whom 14 died and 3 were
ransferred to another ICU, leaving 63 patients included in the ﬁnal
nalysis; 31 for the baseline period and 32 in the group following
he introduction of the Sara Combilizer (see Fig. 4). Subjects were
ell matched in terms of age, gender, pre admission functional
evel and preexisting comorbidities, although patients in the Sara
ombilizer phase had signiﬁcantly higher illness severity scores on
dmission to critical care. There were also signiﬁcant differencesPlease cite this article in press as: McWilliams D, et al. The Sara Com
prospective before and after study. Aust Crit Care (2016), http://dx.doi
oted regarding admission speciality (see Table 1). Five patients
n each group only commenced mobilisation after discharge from
he ICU. There was no statistical difference in the total duration of
hysiotherapy received by each group. When the Sara Combilizere stren gth
tructured mobility protocol.
was made available, it was  used in 47% of the total patient cohort,
a mean of 2.6 times per patient.
The differences in all measured outcomes are shown in Table 2.
There was  a signiﬁcant reduction in time to mobilise following
introduction of the Sara Combilizer (geometric mean (95% CI): 10.6
(9.1–12.4) vs. 13.6 (11.7–15.8) days, p = 0.028), with SOFA scores
also signiﬁcantly higher at the point of mobilisation in the Sara
Combilizer group (mean (SD): 5.1 (2.4) vs. 2.9 (1.2), p = 0.005). No
signiﬁcant differences were observed in the duration of mechan-
ical ventilation, ICU length of stay, or any additional outcomes in
the Sara Combilizer phase (Table 3).
No other signiﬁcant differences were observed for any of the
physical or psychological outcomes. Barthel scores indicated a sig-
niﬁcant loss of function as a result of critical illness, with subjects
in both groups almost completely dependent at the point of criti-
cal care discharge. Although improvement was seen by the point ofbilizer® as an early mobilisation aid for critically ill patients: A
.org/10.1016/j.aucc.2016.09.001
hospital discharge, this had still not returned to baseline levels and
no signiﬁcant differences were seen in the level of functional recov-
ery between groups at either critical care or hospital discharge.
There was no difference in HADS between groups, although less
ARTICLE IN PRESSG ModelAUCC-338; No. of Pages 7
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A
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A
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- Poor  baseli ne mobili ty (7)  
- Neur omuscular conditi on (6)  
- Lower li mb  ampu tations  (1)   
Fig. 4. Participant ﬂow diagram.
Table 1
Patient demographics and physiotherapy treatment time.
Baseline group
(n = 31)
Sara Combilizer
group (N = 32)
p-Value
Age 49.6 (15.8) 48.9 (17.7) 0.868
Gender (% male) 21 (68%) 20 (63%) 0.793
Charlson Comorbidity Index# 1 (0, 1) 1 (0, 2) 0.410
SOFA score at recruitment 6.7 (2.8) 7.3 (2.9) 0.430
Apache II score 12.7 (5.0) 16.0 (6.9) 0.037*
Pre admission Barthel (% with
score of 20)
29 (94%) 31 (97%) 0.613
Admission speciality 0.039*
Burns/trauma 7 (23%) 3 (9%)
General surgery 2 (6%) 4 (13%)
Medical 2 (6%) 10 (31%)
Neurological 20 (65%) 15 (47%)
Chronic respiratory disease 3 (10%) 1 (3%) 0.355
Previous signiﬁcant cardiac
disease
0 (0%) 2 (6%) 0.492
End  stage renal failure 0 (0%) 1 (3%) 1.000
Chronic liver disease 0 (0%) 1 (3%) 1.000
Reported as mean (SD), with p-values from t-tests or N (%), with p-values from
Fisher’s exact test, unless stated otherwise.
# Medians and IQR, with p-values from Mann–Whitney tests.
* Signiﬁcant at p < 0.05.
t
o
s
Table 2
Time to ﬁrst mobilisation and other outcome measures.
Baseline group
(n = 31)
Sara Combilizer
group (n = 32)
p-Value
Sara Combilizer used 0 (0%) 15 (47%) –
Mean total duration of
physiotherapy (min)
503 (142) 348 (210) 0.103
Time to ﬁrst
mobilisation (days)
13.6 (11.7–15.8) 10.6 (9.1–12.4) 0.028*
SOFA score at 1st
mobilisation#
2.9 (0.5) 5.1 (2.4) 0.005*
Sedation days 7.2 (5.9–8.7) 5.6 (4.7–6.6) 0.066
Ventilation days† 11 (6, 15) 8 (6, 12) 0.104
ICU  dependency days 15.6 (12.9–19.0) 13.3 (11.4–15.5) 0.201
ICU  length of stay
(days)
17.1 (14.3–20.5) 15.3 (13.3–17.5) 0.331
All variables completed for all patients and reported as geometric mean (95% CI),
with p-values from t-tests on logged values, unless stated otherwise.
# Reported as mean (SD), with p-value from a t-test. SOFA scores calculated for
patients mobilising within the ICU only.
† Reported as median (IQR), with p-value from a Mann–Whitney test.
mechanically ventilated for greater than ﬁve days within critical
care. This was  achieved despite the therapy time remaining similar.han 50% of patients were able to complete this due to confusion
r reduced consciousness. Completion of the MRC  sum scores wasPlease cite this article in press as: McWilliams D, et al. The Sara Com
prospective before and after study. Aust Crit Care (2016), http://dx.doi
imilarly limited.* Signiﬁcant at p < 0.05.
6. Discussion
The introduction of the Sara Combilizer was associated with a
signiﬁcant reduction in the time to ﬁrst mobilisation for patientsbilizer® as an early mobilisation aid for critically ill patients: A
.org/10.1016/j.aucc.2016.09.001
Patients’ SOFA scores were higher at the time of ﬁrst mobilisation in
ARTICLE ING ModelAUCC-338; No. of Pages 7
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Table 3
Additional outcomes.
Baseline group
(n = 31)
Sara Combilizer
group (n = 32)
p-Value
Barthel score at ICU discharge 1 (0, 3) 2 (0, 7) 0.267
Barthel score at hospital
discharge
13 (2, 19) 15 (2, 18) 0.850
Anxiety score at ICU discharge 11 (7, 12)
[n = 12]
4 (2, 8)
[n = 11]
0.103
Anxiety score at hospital
discharge
8 (3, 11)
[n = 16]
3 (2, 6)
[n = 15]
0.321
Depression score at ICU
discharge
7 (3, 13)
[n = 12]
3 (2, 7)
[n = 11]
0.282
Depression score at hospital
discharge
5 (2, 11)
[n = 16]
6 (3, 10)
[n = 15]
0.843
MRC  sum score at ICU
discharge
51 (41, 54)
[n = 16]
47 (34, 56)
[n = 22]
0.579
MRC  sum score at hospital
discharge
58 (48, 60)
[n = 19]
54 (50, 60)
[n = 27]
0.855
Readmission to ICU—n (%) 3 (10%) 1 (3%) 0.355
Falls on ward—n (%) 4 (13%) 4 (13%) 1.000
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teported as median (IQR), with p-values from Mann–Whitney tests, or as N (%), with
-values from Fisher’s exact test, as applicable.
he Sara Combilizer group, suggesting they were in a greater degree
f organ failure whilst mobilising.
Advances in rehabilitation practice within critical care have
emonstrated signiﬁcant beneﬁt. Improvements in strength, func-
ion and mobility serve to reduce the impact of a period of critical
llness, whilst the reductions in LOS results in both costs savings and
ore efﬁcient utilisation of resource within critical care units.25
he key message from national guidance in this area is to start
ehabilitation as early as clinically possible,26 although no exact
eﬁnition currently exists on what ‘early’ really means. Previous
esearch has attempted to identify speciﬁc barriers to early mobil-
sation, ﬁnding factors such as the presence of an endotracheal
ube, reduced conscious levels and hemoﬁltration lines as common
arriers. Organisational factors also play a part, with limitations
eported due to reduced stafﬁng levels and concerns regarding
atient and caregiver safety.19,20,27 We  speciﬁcally assessed the
mpact of a device designed to facilitate mobility of patients who
ould otherwise be conﬁned to bed, in a cohort at high risk of
CUAW. We  have demonstrated the introduction of this mode of
ransfer to be an effective method of reducing the time taken to
rst mobilise within critical care. Importantly, SOFA scores conﬁrm
his occurred during a more acute stage of the patients’ illness.
The strengths of this study are that it was appropriately powered
o detect the primary outcome of time to mobilise and that recruit-
ent targets were achieved in the speciﬁed time frame. The one
onth training and familiarisation period allowed training to be
elivered to the nursing and physiotherapy teams working within
ritical care. The development of a protocol also provided some
uidance on use of the device. Although the reduced time taken
o mobilise (10.6 days) for the Sara Combilizer group may  appear
lower than previously published studies, the speciﬁc population
tudied were those still sedated and mechanically ventilated at
ecruitment with more potential restrictions to mobilise. The Sara
ombilizer allowed mobilisation of patients at a time when SOFA
cores were signiﬁcantly higher, potentially supporting mobilisa-
ion at an earlier time point in their illness and recovery than would
therwise have been possible.
One major limitation to our ﬁndings is the before and after
ature of the study. As the devices were made freely available
o all staff, a randomised design within a single centre wouldPlease cite this article in press as: McWilliams D, et al. The Sara Com
prospective before and after study. Aust Crit Care (2016), http://dx.doi
ave led to high risk of contamination. Population variations may
ave impacted on results. The baseline data collection occurred
uring the summer months and included a higher proportion of
rauma and neurological patients, who may  have different recovery PRESS
tical Care xxx (2016) xxx–xxx
trajectories to the more medical population seen in the Sara Com-
bilizer group. Patients with speciﬁc exclusions to mobilise such as
lower limb fractures or spinal injuries were however excluded from
the study which should have limited the impact of this. Subjects
were otherwise well matched at baseline, although the interven-
tion group did present with a higher illness severity on admission.
No formal change in sedation practice occurred, but there was  a
non-signiﬁcant reduction in the number of sedation days in the
intervention group in comparison to baseline. This may  have meant
patients were more alert and therefore able to commence mobil-
isation at an earlier time point. Certainly previous research has
demonstrated the link between reductions in duration of sedation
and improved outcomes.28
Use of the Sara Combilizer was  supported by a mobility protocol,
and was utilised in 47% of the patients for whom it was made avail-
able. It was impossible and may  have been counterproductive to
mandate use, as some patients were ready to progress with mobil-
ising through the protocol at a faster rate, and therefore use may
paradoxically have held progress back. As such, the Sara Combi-
lizer protocol speciﬁcally recommended its use for patients with
a delayed ability to mobilise or restrictions which may  have pre-
viously deemed mobilisation unsafe. Only 23 of the 63 patients in
the 2 groups were able to complete all of the outcome measures of
Barthel, HADS and MRC  sum score, demonstrating the difﬁculties
in using such scoring systems as outcome measures in critical care
trials.
Despite the reduced time to mobilise no changes were seen in
either physical or psychological outcomes from use of the device,
although it is acknowledged the study was not speciﬁcally pow-
ered to detect such changes. Further research is required to conﬁrm
these ﬁndings and future evaluations of this and similar devices
should be conducted as a multi-site cluster randomised trial due to
the high potential for contamination between groups. It would be
useful to explore the impact of the device for speciﬁc populations
with signiﬁcant restrictions to early mobilisation (e.g. neurosurgi-
cal or trauma patients) who  may  have been excluded from previous
trials in this area. A lack of impact of early mobility has been seen in
a number of recently published studies.29–31 This may in some part
be due to the inclusion of patients with shorter ICU lengths of stay or
lower illness severity scores. thus meaning they may be less likely
to require or show beneﬁt from the intervention. Future studies
should carefully consider inclusion and exclusion criteria in more
detail to ensure rehabilitation is evaluated for speciﬁc populations
most at need. More information regarding the speciﬁc barriers to
mobilisation may  also help to provide greater insight into the lack
of translation seen into clinical practice.
7. Conclusions
The introduction of the Sara Combilizer was associated with a
signiﬁcant reduction in time to mobilise in patients mechanically
ventilated for ≥5 days and at high risk of the long term sequelae
from critical illness. The degree of organ failure, assessed using
SOFA scores, was signiﬁcantly higher during mobilisation in the
Combilizer group suggesting patients were being mobilised at a
more acute stage of their critical illness. The Sara Combilizer may  be
a useful adjunct to early mobilisation protocols for patients within
the ICU.
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